Literature DB >> 20186153

Protein phosphatase-1 regulates Akt1 signal transduction pathway to control gene expression, cell survival and differentiation.

L Xiao1, L-L Gong, D Yuan, M Deng, X-M Zeng, L-L Chen, L Zhang, Qin Yan, J-P Liu, X-H Hu, S-M Sun, J Liu, H-L Ma, C-B Zheng, H Fu, P-C Chen, J-Q Zhao, S-S Xie, L-J Zou, Y-M Xiao, W-B Liu, J Zhang, Y Liu, D W-C Li.   

Abstract

AKT pathway has a critical role in mediating signaling transductions for cell proliferation, differentiation and survival. Previous studies have shown that AKT activation is achieved through a series of phosphorylation steps: first, AKT is phosphorylated at Thr-450 by JNK kinases to prime its activation; then, phosphoinositide-dependent kinase 1 phosphorylates AKT at Thr-308 to expose the Ser-473 residue; and finally, AKT is phosphorylated at Ser-473 by several kinases (PKD2 and others) to achieve its full activation. For its inactivation, the PH-domain containing phosphatases dephosphorylate AKT at Ser-473, and protein serine/threonine phosphatase-2A (PP-2A) dephosphorylates it at Thr-308. However, it remains unknown regarding which phosphatase dephosphorylates AKT at Thr-450 during its inactivation. In this study, we present both in vitro and in vivo evidence to show that protein serine/threonine phosphatase-1 (PP-1) is a major phosphatase that directly dephosphorylates AKT to modulate its activation. First, purified PP-1 directly dephosphorylates AKT in vitro. Second, immunoprecipitation and immunocolocalization showed that PP-1 interacts with AKT. Third, stable knock down of PP-1alpha or PP-1beta but not PP-1gamma, PP-2Aalpha or PP-2Abeta by shRNA leads to enhanced phosphorylation of AKT at Thr-450. Finally, overexpression of PP-1alpha or PP-1beta but not PP-1gamma, PP-2Aalpha or PP-2Abeta results in attenuated phosphorylation of AKT at Thr-450. Moreover, our results also show that dephosphorylation of AKT by PP-1 significantly modulates its functions in regulating the expression of downstream genes, promoting cell survival and modulating differentiation. These results show that PP-1 acts as a major phosphatase to dephosphorylate AKT at Thr-450 and thus modulate its functions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20186153     DOI: 10.1038/cdd.2010.16

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  35 in total

1.  Enzyme-sharing as a cause of multi-stationarity in signalling systems.

Authors:  Elisenda Feliu; Carsten Wiuf
Journal:  J R Soc Interface       Date:  2011-11-02       Impact factor: 4.118

2.  Sumoylation activates the transcriptional activity of Pax-6, an important transcription factor for eye and brain development.

Authors:  Qin Yan; Lili Gong; Mi Deng; Lan Zhang; Shuming Sun; Jiao Liu; Haili Ma; Dan Yuan; Pei-Chao Chen; Xiaohui Hu; Jinping Liu; Jichao Qin; Ling Xiao; Xiao-Qin Huang; Jian Zhang; David Wan-Cheng Li
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-17       Impact factor: 11.205

Review 3.  Novel Ser/Thr protein phosphatases in cell death regulation.

Authors:  Haipeng Sun; Yibin Wang
Journal:  Physiology (Bethesda)       Date:  2012-02

4.  Human cytomegalovirus phosphoproteins are hypophosphorylated and intrinsically disordered.

Authors:  Franz J J Rieder; Marie-Theres Kastner; Markus Hartl; Martin G Puchinger; Martina Schneider; Otto Majdic; William J Britt; Kristina Djinović-Carugo; Christoph Steininger
Journal:  J Gen Virol       Date:  2017-04-01       Impact factor: 3.891

5.  Combination of zoledronic acid and serine/threonine phosphatase inhibitors induces synergistic cytotoxicity and apoptosis in human breast cancer cells via inhibition of PI3K/Akt pathway.

Authors:  Zeki Surmeli; Pinar Gursoy; Atike Pinar Erdogan; Emir Bozkurt; Harika Atmaca; Selim Uzunoglu; Canfeza Sezgin; Ulus Ali Şanlı; Ruchan Uslu; Burcak Karaca
Journal:  Tumour Biol       Date:  2015-10-13

6.  The impact of cruciferous vegetable isothiocyanates on histone acetylation and histone phosphorylation in bladder cancer.

Authors:  Besma Abbaoui; Kelly H Telu; Christopher R Lucas; Jennifer M Thomas-Ahner; Steven J Schwartz; Steven K Clinton; Michael A Freitas; Amir Mortazavi
Journal:  J Proteomics       Date:  2017-01-27       Impact factor: 4.044

7.  Amino acids activate mammalian target of rapamycin complex 2 (mTORC2) via PI3K/Akt signaling.

Authors:  Irantzu Tato; Ramon Bartrons; Francesc Ventura; Jose Luis Rosa
Journal:  J Biol Chem       Date:  2010-12-03       Impact factor: 5.157

8.  NEK2 induces drug resistance mainly through activation of efflux drug pumps and is associated with poor prognosis in myeloma and other cancers.

Authors:  Wen Zhou; Ye Yang; Jiliang Xia; He Wang; Mohamed E Salama; Wei Xiong; Hongwei Xu; Shashirekha Shetty; Tiehua Chen; Zhaoyang Zeng; Lei Shi; Maurizio Zangari; Rodney Miles; David Bearss; Guido Tricot; Fenghuang Zhan
Journal:  Cancer Cell       Date:  2013-01-14       Impact factor: 31.743

9.  Akt2 and acid ceramidase cooperate to induce cell invasion and resistance to apoptosis.

Authors:  Norbert Berndt; Ronil Patel; Hua Yang; Maria E Balasis; Saïd M Sebti
Journal:  Cell Cycle       Date:  2013-06-06       Impact factor: 4.534

Review 10.  Therapeutic melting pot of never in mitosis gene a related kinase 2 (Nek2): a perspective on Nek2 as an oncology target and recent advancements in Nek2 small molecule inhibition.

Authors:  Brendan Frett; Robert V Brown; Mingliang Ma; Wenhao Hu; Haiyong Han; Hong-yu Li
Journal:  J Med Chem       Date:  2014-02-25       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.